Algert Global LLC Takes $12.42 Million Position in Maximus, Inc. (NYSE:MMS)

Algert Global LLC purchased a new stake in Maximus, Inc. (NYSE:MMS) in the 2nd quarter, HoldingsChannel reports. The firm purchased 144,971 shares of the health services provider’s stock, valued at approximately $12,424,000. Maximus accounts for approximately 0.4% of Algert Global LLC’s investment portfolio, making the stock its 11th biggest position.

A number of other large investors also recently bought and sold shares of the business. UBS Group AG increased its position in shares of Maximus by 60.7% in the fourth quarter. UBS Group AG now owns 72,724 shares of the health services provider’s stock valued at $6,099,000 after buying an additional 27,466 shares in the last quarter. US Bancorp DE lifted its position in shares of Maximus by 20.3% in the fourth quarter. US Bancorp DE now owns 9,843 shares of the health services provider’s stock valued at $825,000 after acquiring an additional 1,664 shares in the last quarter. TD Asset Management Inc increased its position in shares of Maximus by 8.1% during the fourth quarter. TD Asset Management Inc now owns 29,300 shares of the health services provider’s stock worth $2,457,000 after purchasing an additional 2,200 shares in the last quarter. RK Capital Management LLC acquired a new position in Maximus in the 4th quarter valued at $4,377,000. Finally, Public Employees Retirement Association of Colorado lifted its holdings in Maximus by 1,984.0% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 335,094 shares of the health services provider’s stock valued at $28,101,000 after purchasing an additional 319,015 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Price Performance

Maximus stock opened at $92.70 on Friday. The company has a fifty day simple moving average of $89.92 and a 200-day simple moving average of $86.38. The firm has a market capitalization of $5.64 billion, a price-to-earnings ratio of 24.33 and a beta of 0.76. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61. Maximus, Inc. has a 52-week low of $72.39 and a 52-week high of $93.97.

Maximus (NYSE:MMS) last released its quarterly earnings data on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.27. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.59% and a return on equity of 20.91%. Maximus’s quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.78 EPS. On average, equities analysts anticipate that Maximus, Inc. will post 6.12 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Saturday, August 31st. Stockholders of record on Thursday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date was Thursday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.29%. Maximus’s dividend payout ratio is presently 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.